Differences in the released endothelial microparticle subtypes between human pulmonary microvascular endothelial cells and aortic endothelial cells in vitro

Experimental Lung Research

Volumn 39, Issue 4-5, 2013, Pages 155-161

  Takahashi, Toru ^a,b   Kobayashi, Seiichi ^c   Fujino, Naoya ^a   Suzuki, Takaya ^d   Ota, Chiharu ^a   Tando, Yukiko ^a   He, Mei ^a   Yamada, Mitsuhiro ^a   Kurosawa, Shin ^b   Yamaya, Mutsuo ^a   Kubo, Hiroshi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c JAPANESE RED CROSS SOCIETY   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

Author keywords

Chronic obstructive pulmonary disease; Cigarette smoke; Endothelial cells; Inflammation; Oxidative stress

Indexed keywords

CD146 ANTIGEN; CD31 ANTIGEN; CIGARETTE SMOKE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN RECEPTOR; HYDROGEN PEROXIDE; NICOTINE; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR ENDOTHELIAL CADHERIN; AUTACOID; BIOLOGICAL MARKER; CYTOKINE; OXIDIZING AGENT; SMOKE;

ANTIGEN EXPRESSION; AORTA; ARTICLE; CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FILTRATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LUNG; MICROVASCULAR ENDOTHELIAL CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; SMOKING HABIT; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; MEMBRANE MICROPARTICLE; METABOLISM; MICROVASCULATURE; SMOKE; SMOKING; TOXICITY; VASCULARIZATION;

AORTA; BIOLOGICAL MARKERS; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; CYTOKINES; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; LUNG; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROVESSELS; OXIDANTS; OXIDATIVE STRESS; SMOKE; SMOKING;

EID: 84877993992     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2013.784932     Document Type: Article

References (30)

1. Diamant M, Tushuizen ME, Sturk A, Nieuwland R: Cellular microparticles: New players in the field of vascular disease? Eur J Clin Invest. 2004;34:392-401.
2. Freyssinet JM: Cellular microparticles: What are they bad or good for? J Thromb Haemost. 2003;1:1655-1662.
3. Takahashi T, Kobayashi S, Fujino N, Suzuki T, Ota C, He M, Yamada M, Suzuki S, Yanai M, Kurosawa S, Yamaya M, Kubo H: Increased circulating endothelial microparticles in COPD patients: Apotential biomarker for COPD exacerbation susceptibility. Thorax. 2012;67:1067-1074.
4. Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, Sumida H, Matsui K, Jinnouchi H, Ogawa H: Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol. 2009;54:601-608.
5. Mostefai HA, Meziani F, Mastronardi ML, Agouni A, Heymes C, Sargentini C, Asfar P, Martinez MC, Andriantsitohaina R: Circulating microparticles from patients with septic shock exert protective role in vascular function. Am J Respir Crit Care Med. 2008;178:1148-1155.
6. Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, LondonGM, Tedgui A, Boulanger CM: Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol. 2005;16:3381-3388 Bevilacqua M, Butcher E, Furie B, Furie B, Gallatin M, Gimbrone M, Harlan J, Kishimoto K, Lasky L, McEver R,
7. Bevilacqua M, Butcher E, Furie B, Gallatin M, Gimbrone M, Harlan J, Kishimoto K, Lasky L, McEver R, Paulson J, Rosen S, Seed B, SiegelmanM, Springer T, Stoolman L, Tedder T, Varki A, Wagner D, Weissman I, Zimmerman G: Selectins: Afamily of adhesion receptors. Cell. 1991;67:233.
8. Thorin E, Shreeve SM: Heterogeneity of vascular endothelial cells in normal and disease states. Pharmacol Ther. 1998;78:155-166.
9. Gerritsen ME: Functional heterogeneity of vascular endothelial cells. Biochem Pharmacol. 1987;36:2701-2711.
10. Muller AM, Hermanns MI, Skrzynski C, Nesslinger M, Muller KM, Kirkpatrick CJ: Expression of the endothelial markers PECAM-1, vWf, and CD34 in vivo and in vitro. Exp Mol Pathol. 2002;72:221-229.
11. Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt AY, Large SR, Wells FC, Wallwork J: Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med. 1991;324:1539-1547.
12. Iwamoto H, Yokoyama A, Kitahara Y, Ishikawa N, Haruta Y, Yamane K, Hattori N, Hara H, Kohno N: Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med. 2009;179:35-40.
13. Takahashi T, Suzuki S, Kubo H, Yamaya M, Kurosawa S, Kato M: Impaired endothelial progenitor cell mobilization and colony-forming capacity in chronic obstructive pulmonary disease. Respirology. 2011;16:680-687.
14. Barr RG, Mesia-Vela S, Austin JH, Basner RC, Keller BM, Reeves AP, Shimbo D, Stevenson L: Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: The Emphysema and Cancer Action Project (EMCAP) Study. Am J Respir Crit Care Med. 2007;176:1200-1207.
15. Fabbri LM, Rabe KF: From COPD to chronic systemic inflammatory syndrome? Lancet. 2007;370:797-799.
16. Tanabe N, Muro S, Hirai T, Oguma T, Terada K, Marumo S, Kinose D, Ogawa E, Hoshino Y, Mishima M: Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183:1653-1659.
17. Fabbri LM, Beghe B, Agusti A: Cardiovascular mechanisms of death in severe COPD exacerbation: Time to think and act beyond guidelines. Thorax. 2011;66:745-747.
18. Di Stefano A, Caramori G, Ricciardolo FL, Capelli A, Adcock IM, Donner CF: Cellular and molecular mechanisms in chronic obstructive pulmonary disease: An overview. Clin Exp Allergy. 2004;34:1156-1167.
19. Rahman I: Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: Cellular and molecular mechanisms. Cell Biochem Biophys. 2005;43:167-188.
20. Bernhard D, Pfister G, Huck CW, Kind M, Salvenmoser W, Bonn GK, Wick G: Disruption of vascular endothelial homeostasis by tobacco smoke: Impact on atherosclerosis. FASEB J. 2003;17:2302-2304.
21. Milara J, Ortiz JL, Juan G, Guijarro R, Almudever P, Martorell M, Morcillo EJ, Cortijo J: Cigarette smoke exposure up-regulates endothelin receptor B in human pulmonary artery endothelial cells: Molecular and functional consequences. Br J Pharmacol. 2010;161:1599-1615.
22. van Ierssel SH, Van Craenenbroeck EM, Conraads VM, Van Tendeloo VF, Vrints CJ, Jorens PG, Hoymans VY: Flow cytometric detection of endothelial microparticles (EMP): Effects of centrifugation and storage alter with the phenotype studied. Thromb Res. 2010;125:332-339.
23. Beyer C, Pisetsky DS: The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol. 2010;6:21-29.
24. Berda-Haddad Y, Robert S, Salers P, Zekraoui L, Farnarier C, Dinarello CA, Dignat-George F, Kaplanski G: Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1alpha. Proc Natl Acad Sci USA. 2011;108:20684-20689.
25. Pauwels NS, Bracke KR, Dupont LL, Van Pottelberge GR, Provoost S, Vanden Berghe T, Vandenabeele P, Lambrecht BN, Joos GF, Brusselle GG: Role of IL-1alpha and the Nlrp3/caspase-1/IL-1beta axis in cigarette smokeinduced pulmonary inflammation and COPD. Eur Respir J. 2011;38:1019-1028.
26. Shapiro SD, Goldstein NM, Houghton AM, Kobayashi DK, Kelley D, Belaaouaj A: Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol. 2003;163:2329-2335.
27. Gordon C, Gudi K, Krause A, Sackrowitz R, Harvey BG, Strulovici-Barel Y, Mezey JG, Crystal RG: Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med. 2011;184:224-232.
28. Polosa R., Malerba M., Cacciola RR, Morjaria JB, Maugeri C, Prosperini G, Gullo R, Spicuzza L, Radaeli A, Di Maria GU: Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients. Intern EmergMed. 2011. doi:10.1007/s11739-011-0636-1.
29. Polosa R, Cacciola RR, Prosperini G, Spicuzza L, Morjaria JB, Di Maria GU: Endothelial-coagulative activation during chronic obstructive pulmonary disease exacerbations. Haematologica. 2008;93:1275-1276.
30. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS: Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res. 2003;109:175-180.